Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
CELULARITY
Show more
Manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting
Class 40 – Materials treatment
Status timeline
- 17 Feb 2022Application filedNew Application Entered
- 1 Mar 2022Assigned to an examining attorneyAssigned To Examiner
- 11 Mar 2022Approved for publicationApproved For Pub - Principal Register
- 19 Apr 2022Published for oppositionPublished For Opposition
- 5 Jul 2022Registered on the Principal RegisterRegistered-Principal Register
- 7 Jan 2026Ownership assignment recordedAutomatic Update Of Assignment Of Ownership
All 15 events
| 2026-01-07 | Automatic Update Of Assignment Of Ownership |
| 2022-07-05 | Registered-Principal Register |
| 2022-07-05 | Notice Of Registration Confirmation Emailed |
| 2022-04-19 | Published For Opposition |
| 2022-04-19 | Official Gazette Publication Confirmation E-Mailed |
| 2022-03-30 | Notification Of Notice Of Publication E-Mailed |
| 2022-03-15 | Assigned To Lie |
| 2022-03-11 | Examiners Amendment -Written |
| 2022-03-11 | Examiners Amendment E-Mailed |
| 2022-03-11 | Notification Of Examiners Amendment E-Mailed |
| 2022-03-11 | Examiner's Amendment Entered |
| 2022-03-11 | Approved For Pub - Principal Register |
| 2022-03-01 | Assigned To Examiner |
| 2022-02-18 | New Application Office Supplied Data Entered |
| 2022-02-17 | New Application Entered |
Goods & services by class
Class 40 Materials treatment
Manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting
First use anywhere 21 Feb 2018 · First use in commerce 21 Feb 2018
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 8 Jan 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.